Primary Packaging plays an important role in the
pharma industry, where its purpose ranges beyond providing barrier protection
to creating unique brand identity, brand protection and patient communication.
The global pharma packaging industry is booming with modernization, courtesy
several drivers in the technology innovation segment, with India being the hub
of Pharma.
At the recently held CPHI India in Greater Noida, a
gathering of Pharma manufacturers and professionals from across the world,
Indian flexible packaging giant Uflex steered the path of innovation by
unveiling a portfolio of its latest products in pharma packaging- Fast Tear
Strip Foil, PET based Cold Form Blister, Child Resistant & Senior Friendly
Foil and Branding Solutions- for pharmaceutical companies.
Fast Tear Strip Foil: Conventionally, Pharma
companies have been using 30 and 40micron soft tempered Strip Foil pack
laminate. Uflex has developed 20micron pin-hole free soft tempered foil. It
contributes in providing higher yield gain of 36% leading to tremendous cost
savings for Pharma companies. Offering excellent printing on matt finish with
superior readability through multi-color reverse printing design on Special PET
film in Special PET/Foil/PE laminate; Fast Tear Strip Foil is produced in house
to impart easy tear-ability of the laminate without any effort. Fast Tear Strip
Foil maintains the bursting pressure of the pocket with reduced foil thickness.
The value addition of holography solution with Latentogram imparts brand
protection of the pack and maintains the same barrier properties when compared
to that of conventional strip pack laminate. This foil conforms to all
regulatory requirements of pharmaceutical products and also meets toxicology
requirements.
PET based Cold Form Blister: In the conventional
Cold Form Laminate, there are three layers – Nylon, Aluminum and PVC. Uflex has
developed revolutionary Alu-Alu packaging where special polyester film has
replaced the conventional Nylon and PVC while retaining Aluminum making it an
indigenous product since both PVC and BON have to be imported from other
countries. For this unique development, Uflex has also been granted a United
States Patent recently. Alu-Alu packaging provides sustainability and cost
optimization giving it an edge over conventional Alu-Alu packaging.
Child Resistant & Senior Friendly (CRSF) Foil:
The Child Resistant & Senior Friendly (CRSF) Foils, developed by Uflex, are
available in two types Push-Through and Peel-Push. As the name suggests, it
requires some amount of pressure for a child to open it. However an adult or
senior can open it easily. This protects unintentional damage to the foil which
is common with conventional blister foils which get easily tampered during
handling affecting the formulation. CRSF Foils are also commonly used in
regulated markets. With this product portfolio, Uflex will be able to bridge
the gap which is existing currently.
Brand Identity and Protection Solutions: Pharma
brands face two major problems namely Counterfeiting and Medication
Non-Adherence in case of chronic therapies. Considering the literacy levels and
linguistic diversity of India, Uflex offers tailor-made Consumer Discernible
Packaging Solutions which provides Unique Brand Identity and top-of-mind
medication adherence communication along with highly specialized brand
protection packaging technologies. By introducing non-duplicable
anti-counterfeiting overt and covert technologies, pharma industry stands to
gain by checking the challenge of spurious drugs in the market.
Amitava Ray, Executive Director, Uflex Ltd. threw
light on the showcase by stating, “Uflex approach to business is to grow and
develop consumer friendly products than just be a ‘me too’ in the industry.
This is why we ceaselessly work towards delivering an amalgamation of
un-interrupted supplies, quality, service and innovation that are expected in
pharma packaging business.”
On the opportunity that the developed products
offer, Mr. Ray added, “Fast Tear Strip Foil will prove to be a game-changer for
the pharma industry globally and we see a potential growth market of 5000
tonnes annually in India. We are investing in technology, capex and time to
raise the bar both in terms of quality and growth.”
After the display of these products at CPHI, they
have been launched for Indian pharma markets.
